Alex Zisson

Managing Director
H.I.G. BioVentures

Current Summit Page

Alex has been with Thomas, McNerney & Partners since its first fund was raised in 2002. He currently serves on the board of directors for Auspex Pharmaceuticals, Clarus Therapeutics, and Keystone Dental. Alex is a member of the Industry Advisory Board of the Childrens Tumor Foundation, and a board member of Advanced Medical Research Institute of Canada Development Corporation (AMRIC-DC), which is focused on economic development in northern Ontario. He is also an advisor for the Partnership Fund of NYC, which manages a bioaccelarator to advance local healthcare research and is on the Life Sciences Council for Springboard Enterprises, a group that assists female entrepreneurs. Prior to Thomas, McNerney, Alex spent 11 years in the research department at Hambrecht & Quist (and its successor firms Chase H&Q and JPMorgan). During his tenure at H&Q, Alex led research teams covering the biotechnology, specialty pharmaceuticals, large-cap pharmaceuticals, drug delivery and diagnostics industries. After the merger of Chase H&Q and JPMorgan, Alex also became the firms healthcare strategist. He was named twice in The Wall Street Journal All-Star Analysts Survey, including his last year at JPMorgan in which he placed in all three categories: stock picking (#1 in pharmaceuticals), earnings estimate accuracy (tied for #2), and ‘home run’ hitting (#8 across all industries). He graduated magna cum laude from Brown University, where he was elected to Phi Beta Kappa.

Alex is attending / has attended:

The 2016 New York Venture Summit
The 2015 New York Venture Summit
The 2014 New York Venture Summit
The 2013 New York Venture Summit
The Life Sciences and Healthcare Venture Summit 2013
The 2012 New York Venture Summit
The Life Sciences and Healthcare Venture Summit 2012

Join over 300k Investors And Innovators

Sign up now to stay up-to-date with all our events, news, deals and more!